Beam TherapeuticsInc Stock Valuation

What is the enterprise value of Beam TherapeuticsInc? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Beam TherapeuticsInc, is its stock price multiplied by the total number of shares outstanding, calculating Beam TherapeuticsInc's enterprise value requires a different approach. It uses Beam TherapeuticsInc's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Beam TherapeuticsInc Enterprise Value is relatively stable at the moment as compared to the past year. The company's current Enterprise Value is estimated at 5.37 Billion. Tangible Asset Value is expected to hike to about 1.6 B this year, although the value of Free Cash Flow will most likely fall to (116.1 M).
Beam TherapeuticsInc seems to be undervalued based on Macroaxis valuation methodology. Our model approximates the value of Beam TherapeuticsInc from analyzing the firm fundamentals such as return on equity of (0.40) %, and Operating Margin of (1.72) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
Beam TherapeuticsInc Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Beam TherapeuticsInc's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Beam TherapeuticsInc's intrinsic value based on its ongoing forecasts of Beam TherapeuticsInc's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Beam TherapeuticsInc's closest peers. When choosing an evaluation method for Beam TherapeuticsInc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Beam TherapeuticsInc Investments

328.86 Million

Beam TherapeuticsInc Valuation Drivers Correlation

Many accounts on the financial statements of Beam TherapeuticsInc are highly interrelated and sometimes correlated. Consequently, when conducting Beam TherapeuticsInc's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Beam TherapeuticsInc
Click cells to compare fundamentals

Beam TherapeuticsInc Valuation Trend

Knowing Beam TherapeuticsInc's actual value is paramount for traders to make sound investment determinations. Beam TherapeuticsInc's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Beam TherapeuticsInc's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Beam TherapeuticsInc's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Beam TherapeuticsInc Market Cap

Beam TherapeuticsInc is number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 6.25 Billion. Beam TherapeuticsInc totals roughly 3.13 Billion in market capitalization claiming about 50% of equities under Health Care industry.
Capitalization  Valuation  Revenue  Total debt  Workforce

Beam TherapeuticsInc Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Beam TherapeuticsInc's current stock value. Our valuation model uses many indicators to compare Beam TherapeuticsInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Beam TherapeuticsInc competition to find correlations between indicators driving Beam TherapeuticsInc's intrinsic value. More Info.
Beam TherapeuticsInc is number one stock in price to book category among related companies. It is number one stock in net asset category among related companies making up about  319,290,803  of Net Asset per Price to Book. Average Assets is expected to hike to about 1.1 B this year. Tangible Asset Value is expected to hike to about 1.6 B this year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Beam TherapeuticsInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Beam TherapeuticsInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Beam TherapeuticsInc's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Beam TherapeuticsInc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Beam TherapeuticsInc and how it compares across the competition.

About Beam TherapeuticsInc Valuation

The stock valuation mechanism determines the current worth of Beam TherapeuticsInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Beam TherapeuticsInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Beam TherapeuticsInc based exclusively on its fundamental and basic technical indicators. By analyzing Beam TherapeuticsInc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Beam TherapeuticsInc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Beam TherapeuticsInc. We calculate exposure to Beam TherapeuticsInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Beam TherapeuticsInc's related companies.
Last ReportedProjected for 2022
Gross Profit51.8 M55.9 M

Beam TherapeuticsInc Current Valuation Indicators

Valuation refers to the process of determining the present value of Beam TherapeuticsInc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Beam TherapeuticsInc we look at many different elements of the entity such as Beam TherapeuticsInc's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Beam TherapeuticsInc's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Beam TherapeuticsInc's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Beam TherapeuticsInc, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Beam TherapeuticsInc's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Beam TherapeuticsInc's worth.
Continue to Trending Equities. Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Tools for Beam TherapeuticsInc Stock

When running Beam TherapeuticsInc price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go